Legal Cannabis and CBD Market Sales are on the Rise

Thursday, February 22, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

FinancialBuzz.com News Commentary

NEW YORK, February 22, 2018 /PRNewswire/ --

According to a report

from Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is expected to reach $63.5 billion in 2024, growing at a compound annual growth rate of 21.1
percent during the forecast years. Increasing legalization of cannabis across North American and growing demand for both recreational and medical cannabis are the main factors that drives the legal cannabis market. The report also indicated the benefits of legalizing cannabis, including increasing tax revenue, growing tourism activities, decrease in crime rate and several medical applications. Chineseinvestors.com, Inc. (OTC: CIIX), Medical Marijuana, Inc. (OTC: MJNA), United Cannabis Corporation (OTC: CNAB), CV Sciences, Inc (OTC: CVSI), Cannabis Sativa, Inc. (OTC: CBDS)

A Major segment of the legal cannabis industry is the hemp-derived cannabidiol (CBD) market. According to a report by Forbes, Brightfield Group projects that Hemp-derived cannabidiol (CBD) will be a billion-dollar market in just three years. CBD products do not have any psychotropic effects, and are usually used for medical purposes. Brightfield's data estimates that hemp CBD sales have already hit $170 million in 2016 and at a 55% compound annual growth rate over the next five years the market will cross the billion-dollar mark.

Chineseinvestors.com, Inc. (OTCQB: CIIX) on February 5th announced breaking news, "Its wholly-owned foreign enterprise CBD Biotechnology Co. Ltd. ('CBD Biotech') will launch 4 new hemp infused skin care products and a cutting-edge magnetic mask for the China Market in February 2018. The products have been approved for sale in China by the China Food and Drug Administration ('CFDA'). In November 2017, CBD Biotech launched its successful CBD Magic Hemp Series, an affordable hemp-infused skincare line which gained huge recognition thanks to the online beauty influencer, The Godfather of Beauty.

CBD Biotech follows this successful product introduction with the launch of the new 'Live Oxygen' series, a luxury skincare line that uses nanotechnology to penetrate the skin more effectively and is designed to maximize anti-aging effects and to restore the skin's youthful glow. These products are designed to be safe for all skin types. The line includes:

- The CBD Bio Tech Live Oxygen Cleanser, a gentle daily cleanser;

- The CBD Bio Tech Live Oxygen Toner that hydrates the skin and balances oil, while minimizing pores;

- The CBD Bio Tech Live Oxygen Facial Lotion, a light daily moisturizer; and

- The CBD Bio Tech Live Oxygen Cream that provides a protective layer over the skin

In addition to the luxury Live Oxygen Series, CBD Biotech is launching the CBD Biotech Magnetic Mask, a leading-edge mask that utilizes magnet technology to create a low-grade electromagnetic current, which may help to rejuvenate when combined with its own blend of soothing, hydrating anti-inflammatory ingredients."

Summer Yun, CEO of CBD Biotechnology Co., Ltd., comments, "The growing Chinese middle-class has shown a desire for luxury skincare products. CBD Biotech is meeting market demands by offering cutting-edge products that use the latest skincare technologies and include our exclusive hemp infused formulas."

"CBD Biotech is establishing itself as a leader in the new hemp-infused skincare market in China and intends to grow its market share in the industry by continuing to expand its product lines, developing new, innovative products for target markets, and growing its online following through well-known, Chinese beauty influencers," he added.

Medical Marijuana, Inc. (OTC: MJNA) is the first publicly traded cannabis company in the United States. Recently, the company announced that it is excited to celebrate the 2018 Olympic Games with discounts on its tetrahydrocannabinol (THC)-free cannabidiol (CBD) hemp oil products designed specifically for athletes and those who are subject to drug tests. Medical Marijuana, Inc.'s CBD hemp oil, Real Scientific Hemp Oil-X™ (RSHO-X™), is perfect for athletes because it is free of THC, the compound found in cannabis that is known to get you high. It has become the CBD supplement of choice not only for athletes, but also for small children, first responders and anyone else who is subject to drug tests.

United Cannabis Corporation (OTCQB: CNAB) is a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. On February 1, 2018, the company announced that it has established a Limited Partnership between the Company, LASCO Manufacturing Limited (LASCO) and United Cannabis' Jamaican Partner, Cannabinoid Research & Development Co. Ltd. The Company also announced that it has signed an exclusive License Agreement with LASCO to produce the Company's CBD water and other Bio Nutrient Medicinals in the form of Capsules, Sublinguals, Roll-ons, and Balms for the English-speaking Caribbean and Central America, excluding Mexico.

CV Sciences, Inc (OTCQB: CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. On February 13, 2018, the company announced that its industry dominating brand of finished products, PlusCBD Oil™ will be exhibiting at Natural Products Expo West on March 7-11, in Anaheim, California. PlusCBD Oil™, the #1 brand of hemp CBD products in the natural channel according to SPINS scan data, has achieved nationwide success since the launch of its brand of dietary supplements in 2014.

Cannabis Sativa, Inc. (OTCQB: CBDS) is engaged in the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. On December 4, 2017, the company announced that its subsidiary, PrestoDoctor, is expanding its online medical marijuana recommendation services into New York. PrestoDoctor currently serves patients via both their online platform and with dispensary kiosks operating in California and Nevada and will now extend their online services to patients located in the State of New York.

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For chineseinvestors.com Inc. financial news dissemination and PR services, FinancialBuzz.com expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .

Media Contact: info@financialbuzz.com +1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store